Residency · Residency · Radiation Oncology

Malignant Spinal Cord Compression: Emergency Radiation and Surgical Decompression

Introduction

Malignant spinal cord compression (MSCC) is a critical oncologic emergency that affects approximately 5-10% of cancer patients. Prompt diagnosis and treatment are essential because the neurological outcomes depend heavily on the motor function status at the time treatment begins. This lecture explores the clinical presentation and diagnostic evaluation of MSCC, as well as the roles of corticosteroids, surgery, and radiation therapy in management. Additionally, it reviews prognostic scoring systems that guide treatment decisions.

Pathophysiology

MSCC typically results from epidural metastasis compressing the spinal cord or cauda equina. The most common mechanism, accounting for about 85% of cases, is the posterior extension of tumor from vertebral body metastases. Less frequently, compression arises from paravertebral tumors extending through the neural foramina or from intradural or intramedullary metastases. The compression leads to venous congestion, vasogenic edema, and ischemia, which ultimately cause demyelination and axonal injury. If the compression persists for more than 24 to 48 hours, especially in the setting of complete motor loss, irreversible neurological damage occurs.

Clinical Presentation

Symptoms

Back pain is the most common symptom, occurring in 95% of patients. This pain is usually localized but may have a radicular quality and often worsens with recumbency or Valsalva maneuvers. Motor weakness develops in 60-85% of patients and tends to progress gradually, sometimes starting subtly. Sensory changes, such as numbness or paresthesias below the level of compression, are reported in 40-90% of cases. Autonomic dysfunction, including urinary retention, constipation, and impotence, occurs in 40-60% of patients. A rapid onset of symptoms may indicate acute vascular compromise.

Red Flags

Certain clinical features should raise suspicion for MSCC, especially in patients with known malignancy. New onset back pain, particularly if it wakes the patient from sleep or worsens when lying down, is concerning. Progressive lower extremity weakness or gait instability also signals possible spinal cord involvement. Bladder or bowel dysfunction is a late sign and generally indicates a poor prognosis for neurological recovery.

Diagnostic Workup

Imaging

Magnetic resonance imaging (MRI) of the entire spine with and without gadolinium contrast is the gold standard for diagnosing MSCC. MRI has a sensitivity and specificity exceeding 95% and is essential because 10-30% of patients have epidural disease at multiple spinal levels. When MRI is contraindicated, CT myelography serves as an alternative imaging modality.

Bilsky Grading Scale (Epidural Compression)

The Bilsky grading system classifies the extent of epidural spinal cord compression. Grade 0 indicates bone-only disease without epidural involvement. Grade 1a shows displacement of epidural fat without contact with the spinal cord, while grade 1b involves cord abutment without deformation. Grade 1c denotes cord deformation without signal change. Grade 2 represents cord compression with cerebrospinal fluid (CSF) still visible around the cord, and grade 3 indicates severe cord compression with no visible CSF and circumferential involvement. This grading helps guide surgical decision-making.

Initial Management

Corticosteroids

Dexamethasone should be started immediately upon clinical suspicion of MSCC, even before imaging confirmation. For severe neurological deficits, a high-dose regimen of 96 mg intravenous bolus followed by 24 mg every six hours is recommended. For milder deficits or pain alone, a moderate dose of 10 mg IV bolus followed by 4 mg every six hours is appropriate. Corticosteroids reduce peritumoral edema and may temporarily improve neurological function. After definitive treatment begins, steroids should be tapered over 2 to 4 weeks. It is important to monitor for side effects such as hyperglycemia, gastrointestinal bleeding, and myopathy.

Urgency of Treatment

Treatment urgency depends on the patient's neurological status. Ambulatory patients require intervention within 24 hours to preserve mobility. Non-ambulatory patients with motor loss of less than 48 hours duration should receive emergency treatment, as recovery is still possible. However, patients with paraplegia lasting longer than 48 hours have a very poor prognosis for motor recovery regardless of treatment.

Surgical Decompression

Patchell Trial (Landmark Study)

The landmark Patchell trial randomized patients with MSCC to receive either direct decompressive surgery followed by postoperative radiation therapy or radiation therapy alone. Surgery involved direct decompression followed by 30 Gy of radiation in 10 fractions. The study demonstrated that 84% of patients in the surgery plus radiation group remained ambulatory compared to 57% in the radiation-only group. Furthermore, the duration of maintained ambulation was significantly longer—122 days versus 13 days. These results established surgery combined with radiation as the first-line treatment for appropriate candidates.

Surgical Indications

Surgery is indicated for patients with a single level of compression amenable to decompression, particularly those with Bilsky grade 2 or 3 epidural compression accompanied by neurological deficits. Spinal instability, defined by a Spinal Instability Neoplastic Score (SINS) greater than 12, also warrants surgical intervention. Surgery is appropriate when histology is unknown and tissue diagnosis is needed, in cases of radioresistant tumors such as renal cell carcinoma, melanoma, or sarcoma, and when the patient has an expected survival exceeding three months with adequate performance status.

Contraindications to Surgery

Surgery is contraindicated in patients with multiple non-contiguous levels of compression, diffuse metastatic disease with a life expectancy less than three months, radiosensitive tumors like lymphoma, myeloma, small cell carcinoma, or germ cell tumors that respond well to radiation alone, poor performance status (ECOG 3-4), prohibitive comorbidities, and in those with complete paraplegia lasting more than 48 hours.

Surgical Technique

The standard surgical approach is a posterolateral transpedicular decompression with circumferential cord decompression. Instrumented stabilization is performed when indicated to maintain spinal stability. Minimally invasive separation surgery combined with stereotactic body radiation therapy (SBRT) is an emerging treatment paradigm.

Radiation Therapy

Indications for RT Alone

Radiation therapy alone is appropriate for radiosensitive histologies such as lymphoma, myeloma, small cell carcinoma, and seminoma. It is also indicated for patients who are surgically inoperable, those with multiple levels of compression, or patients with significant comorbidities or limited life expectancy that preclude surgery.

Post-Operative Radiation

The standard postoperative radiation regimen is 30 Gy delivered in 10 fractions, typically initiated 2 to 4 weeks after surgery. An alternative regimen is 20 Gy in 5 fractions. Postoperative SBRT, delivering 24-27 Gy in 3 fractions, is increasingly used following separation surgery.

Fractionation for RT Alone

For radiation therapy without surgery, the most common regimen is 30 Gy in 10 fractions. For patients with shorter life expectancy, 20 Gy in 5 fractions is appropriate. In cases of very limited prognosis (less than 3 months), a single fraction of 8 Gy may be considered. Higher doses beyond 30 Gy do not improve outcomes in conventional palliative radiation.

Treatment Planning

Radiation fields typically cover the involved vertebral body levels plus one level above and below, using anterior-posterior/posterior-anterior (AP/PA) fields or simple three-dimensional conformal techniques. Rapid initiation of treatment is critical, with emergent simulation and radiation delivery within 24 hours whenever feasible. SBRT techniques are reserved for select cases, such as post-separation surgery or reirradiation.

Prognostic Scoring Systems

Modified Tokuhashi Score

The Modified Tokuhashi Score predicts survival based on factors including the primary tumor type, presence of visceral metastases, bone metastases, previous pathological fractures, paraplegia status, and performance status. Scores from 0 to 8 predict survival under six months, favoring conservative or palliative treatment. Scores of 9 to 11 suggest survival between six and twelve months, where palliative or excisional surgery may be considered. Scores of 12 to 15 indicate survival beyond twelve months, supporting excisional surgery.

SINS Score (Spinal Instability)

The Spinal Instability Neoplastic Score (SINS) assesses the need for surgical stabilization. Scores from 0 to 6 indicate stability, 7 to 12 are indeterminate, and 13 to 18 denote instability. A spine surgery consultation is recommended for patients with scores above 6.

Outcomes

Motor Function Recovery

Patients who are ambulatory at presentation maintain ambulation in 70-90% of cases following treatment. Those with motor weakness who are non-ambulatory for less than 48 hours regain ambulation in 30-60% of cases. However, patients with paraplegia lasting more than 48 hours have less than a 5% chance of regaining ambulation. Pre-treatment neurological status remains the strongest predictor of functional outcome.

Histology-Specific Outcomes

Radiosensitive tumors such as lymphoma and myeloma respond excellently to radiation therapy alone, with ambulation rates of 70-80%. Radioresistant tumors derive the greatest benefit from combined surgical decompression and radiation therapy.

Key Clinical Pearls

Malignant spinal cord compression is a true oncologic emergency, and the motor function status before treatment is the most important predictor of neurological outcome. Dexamethasone should be administered immediately upon clinical suspicion without waiting for imaging confirmation. The Patchell trial firmly established that surgery combined with radiation therapy is superior to radiation alone for single-level MSCC in suitable surgical candidates. Radiosensitive histologies, including lymphoma, myeloma, and small cell lung cancer, respond well to radiation therapy alone and typically do not require surgery. Finally, MRI of the entire spine is mandatory because 10-30% of patients have epidural disease at multiple levels.

References

1. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366(9486):643-648.
2. Rades D, Stalpers LJ, Veninga T, et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol. 2005;23(15):3366-3375.
3. Laufer I, Rubin DG, Lis E, et al. The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist. 2013;18(6):744-751.
4. Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease. Spine. 2010;35(22):E1221-E1229.

Read this lecture as Markdown